POLD1 is a protein critical for proofreading and fidelity in DNA replication, and POLD1 mutations are positive predictors for the survival benefit from immune checkpoint blockers, as well as exceptional chemotherapy response in a metastatic colorectal cancer patient [48, 75, 76]. Here, POLD1 is linked to metastatic colorectal cancer.